Physician profile
Steven Alan Feig
NPI 1477691152
$655.84
in general payments reported to CMS, 2019-2025
6 companies · $216 in 2025
The $216 reported for 2025 was more than what 76% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.27 · 2023: $109 · 2024: $236 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $221.86 | 2024-2025 | Dupixent |
| Tris Pharma INC | $154.43 | 2019-2023 | Quillichew Er, Dyanavel Xr, Quillivant |
| Novo Nordisk INC | $116.98 | 2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $98.11 | 2025 | |
| Pfizer INC. | $49.88 | 2019-2023 | |
| Glaxosmithkline, LLC. | $14.58 | 2024 | Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Feig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.